{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:28:40Z","timestamp":1784716120155,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001249","name":"University of Tasmania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.clinthera.2019.08.021","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T14:18:55Z","timestamp":1569680335000},"page":"2446-2451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["High Pyridine Generation in Ceftazidime-Icodextrin Admixtures Used to Treat Peritoneal Dialysis-associated Peritonitis"],"prefix":"10.1016","volume":"41","author":[{"given":"Harpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmanjeet","family":"Harmanjeet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Wanandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Castelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Sud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2019.08.021_bib1","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/ndt\/gfi159","article-title":"ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends","volume":"20","author":"Grassmann","year":"2005","journal-title":"Nephrol Dial Transpl"},{"issue":"19","key":"10.1016\/j.clinthera.2019.08.021_bib2","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2165\/00003495-200363190-00011","article-title":"Icodextrin: a review of its use in peritoneal dialysis","volume":"63","author":"Frampton","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2019.08.021_bib3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000363417","article-title":"Practical considerations when prescribing icodextrin: a narrative review","volume":"39","author":"Silver","year":"2014","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1016\/j.clinthera.2019.08.021_bib4","first-page":"ix21","article-title":"Automated peritoneal dialysis","volume":"20","year":"2005","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.clinthera.2019.08.021_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"ISPD peritonitis recommendations: 2016 update on prevention and treatment","volume":"36","author":"Li","year":"2016","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.clinthera.2019.08.021_bib6","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1128\/AAC.01543-10","article-title":"Pharmacokinetic profiles of ceftazidime after intravenous administration in patients undergoing automated peritoneal dialysis","volume":"55","author":"Kim","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2019.08.021_bib7","first-page":"1","article-title":"NTP technical report on the toxicology and carcinogenesis studies of pyridine (CAS no. 110-86-1) in F344\/N rats, Wistar rats, and B6C3F1 mice (drinking water studies)","volume":"470","year":"2000","journal-title":"Natl Toxicol Program Tech Rep Ser"},{"key":"10.1016\/j.clinthera.2019.08.021_bib8","series-title":"INRS Toxicological Card of Pyridine (FT 85)","year":"2011"},{"key":"10.1016\/j.clinthera.2019.08.021_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archinte.1943.00210010101008","article-title":"Toxicity of pyridine in man","volume":"71","author":"Pollock","year":"1943","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2019.08.021_bib10","series-title":"Test Material: Pyridine. Vol. I. Report to Dynamac Corporation, Rockville, MD","article-title":"90-Day subchronic oral toxicity in rats","author":"Anderson","year":"1987"},{"key":"10.1016\/j.clinthera.2019.08.021_bib11","series-title":"Toxicological Profile for Pyridine. Agency for Toxic Substances and Disease Registry U.S.","year":"1992"},{"key":"10.1016\/j.clinthera.2019.08.021_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0147-6513(83)90071-4","article-title":"Ecotoxicological profile of pyridine","volume":"7","author":"Jori","year":"1983","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.clinthera.2019.08.021_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/00498258009033741","article-title":"Species variations in the N-methylation and quaternization of [14C]pyridine","volume":"10","author":"D'Souza","year":"1980","journal-title":"Xenobiotica"},{"key":"10.1016\/j.clinthera.2019.08.021_bib14","series-title":"Toxicological Profile for Pyridine. Agency for Toxic Substances and Disease Registry U.S.","year":"1992"},{"key":"10.1016\/j.clinthera.2019.08.021_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3747\/pdi.2013.00034","article-title":"Stability of the combination of ceftazidime and cephazolin in icodextrin or pH neutral peritoneal dialysis solution","volume":"34","author":"Patel","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.clinthera.2019.08.021_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3747\/pdi.2017.00115","article-title":"Stability of ceftazidime and heparin in four different types of peritoneal dialysis solutions","volume":"38","author":"Kandel","year":"2018","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.clinthera.2019.08.021_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/ajhp\/zxy035","article-title":"Ceftazidime stability and pyridine toxicity during continuous i.v. infusion","volume":"76","author":"Jones","year":"2019","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2019.08.021_bib18","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/sj.ki.5001916","article-title":"Microbiology and outcomes of peritonitis in North America","volume":"103","author":"Mujais","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clinthera.2019.08.021_bib19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2215\/CJN.00010109","article-title":"Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases","volume":"4","author":"Siva","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2019.08.021_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jns.2019.01.018","article-title":"Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database","volume":"398","author":"Lacroix","year":"2019","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.clinthera.2019.08.021_bib21","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1345\/aph.1L307","article-title":"Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","volume":"42","author":"Grill","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2019.08.021_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0028-3908(03)00188-6","article-title":"Evidence for the involvement of GABA(A) receptor blockage in convulsions induced by cephalosporins","volume":"45","author":"Sugimoto","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinthera.2019.08.021_bib23","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bbrc.2018.04.008","article-title":"Cephalosporin antibiotics are weak blockers of GABAa receptor-mediated synaptic transmission in rat brain slices","volume":"499","author":"Amakhin","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinthera.2019.08.021_bib24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00702-004-0177-0","article-title":"Cefoselis, a beta-lactam antibiotic easily penetrates the blood-brain barrier and causes seizure independently by glutamate release","volume":"111","author":"Ohtaki","year":"2004","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.clinthera.2019.08.021_bib25","first-page":"275","article-title":"The mechanism of ceftazidime degradation in aqueous solutions","volume":"55","author":"Zajac","year":"1998","journal-title":"Acta Pol Pharm"},{"key":"10.1016\/j.clinthera.2019.08.021_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/B:JOBB.0000041758.20071.19","article-title":"Ammonia neurotoxicity and the mitochondrial permeability transition","volume":"36","author":"Norenberg","year":"2004","journal-title":"J\u00a0Bioenerg Biomembr"},{"key":"10.1016\/j.clinthera.2019.08.021_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0272-6386(99)70265-9","article-title":"Pharmacokinetics of intermittent intraperitoneal ceftazidime","volume":"33","author":"Grabe","year":"1999","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819304746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819304746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:51:58Z","timestamp":1758963118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819304746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0149291819304746"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.08.021","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Pyridine Generation in Ceftazidime-Icodextrin Admixtures Used to Treat Peritoneal Dialysis-associated Peritonitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}